Related Experiment Video
Updated: Apr 25, 2026
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Protective effects of melatonin therapy in model for neonatal hyperoxic lung injury
Insights
Melatonin (MT) treatment protected newborn rats from hyperoxic lung injury by reducing lung damage and improving antioxidant levels. This suggests MT may help prevent bronchopulmonary dysplasia (BPD) in premature infants.
Area of Science:
- Neonatal physiology
- Pulmonary medicine
- Pharmacology
Background:
- Bronchopulmonary dysplasia (BPD) is a common complication in premature infants.
- Oxygen toxicity significantly contributes to BPD development.
- Melatonin (MT) possesses antioxidant properties and may offer protection.
Purpose of the Study:
- To investigate the protective effects of melatonin on hyperoxic lung injury in a neonatal rat model.
- To evaluate melatonin's impact on cytoprotection and lung healing.
Main Methods:
- A case-control study involving 60 newborn Sprague-Dawley rats divided into control, hyperoxia-exposed, and melatonin-treated groups.
- Rats were exposed to continuous oxygen for 14 days.
- Lung histopathology, lamellar body counts, and antioxidant enzyme activities (SOD, GSH-Px, MDA) were assessed.
Main Results:
- Melatonin treatment significantly reduced histopathological scores compared to hyperoxia alone.
- Lamellar-body and radial-alveolar counts were higher in the melatonin group.
- Superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) levels increased, while malondialdehyde (MDA) decreased with melatonin treatment.
Conclusions:
- Melatonin therapy demonstrates a protective effect against hyperoxic lung injury in neonatal rats.
- These findings suggest melatonin may be a potential preventive therapy for BPD in preterm infants.
- Further clinical studies are warranted to confirm these results in human infants.
Context:
Bronchopulmonary dysplasia (BPD) is a common outcome of premature birth. Currently, no effective preventive therapy is available for BPD, but the major role of O2 toxicity in the development of BPD has gained attention, particularly for developing new antioxidants for prevention. The major protective mechanism of melatonin (MT) includes free-radical scavenging activity and activation of the cyclooxygenase-prostoglandin enzyme system.
Objective:
The aim of this study was to evaluate the effects of MT on cytoprotection and healing in a model of hyperoxic lung injury in newborn rats.
Methods:
This is a case-control study design.
Setting:
The study occurred at the Gulhane Military Medical Academy in Ankara, Turkey.
Intervention:
A total of 60 newborn pups from dated, Sprague-Dawley, pregnant rats were divided equally into 3 groups as follows: (1) control group, (2) hyperoxia-exposed group, and (3) hyperoxia-exposed plus MT-treated group (MT group). Hyperoxia was performed by placing these pups in an oxygen chamber for 14 d during which oxygen was continuously delivered.
Outcome Measures:
At the end of the 14 d, lung specimens were collected and evaluation of the lamellar-body count and determination of histopathological scores were performed. Also, the activities of superoxide dysmutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) were assessed.
Results:
The histopathological scores of the MT group were significantly lower than those of the hyperoxia-exposed group. The mean lamellar-protein and radial-alveolar counts in the MT group were found to be significantly higher than those of the hyperoxia-exposed group. Also, SOD and GSH-Px levels were significantly higher and MDA levels were significantly lower in the MT group compared with the hyperoxia-exposed group.
Conclusion:
MT therapy was found to have a protective effect in a model for hyperoxic lung injury in neonatal rats. Therefore, the research team suggests that MT therapy may be used for prevention of BPD in preterm infants after confirmation of this data by future clinical studies.
